The Minister of Health and Humanitarian Services was assigned Robert F. Kennedy Junior Food and Drug Administration by conducting a MIFEPRISTONE safety review, a pill used in most American miscarriages. Kennedy said this week that the review was justified due to a new report “warning of danger” about the serious negative events issued last month.
“It is clear that it indicates that at least, the brand must be changed,” Senator Josh Holie, R-MO, said in a Senate group on Wednesday. “I asked Marty Makary, the FDA, to conduct a full review and inform him.”
the The relevant report,, Which was not reviewed by peers and has not been published in a medical journal, claiming to find a higher rate than MIFEPRISTONE serious complications compared to FDA. The agency calls for “further investigation of the harm caused by MEFPresson to women” and “completely reviewing her approval.”
It was released online in April by the Center for Ethics and Public Policy, a conservative research tank that says it is promoting Christian Jewish traditions. It was the center In the project advisory council 2025The right -wing policy initiative, which seems to be informed Many of the recent actions of President Donald Trump.
” He had no plans to take action on MIFEPRISTONE Unless new data suggests that there is anxiety of safety.
Holie, who has Voice constantly to reduce access to miscarriageand Call Makary last month In order to “follow this new data” and restore some of the restrictions that made the MifePrristone it is difficult to obtain, such as the requirements of medications that the doctor must extract personally.
while Wealth of data It has shown that less than 0.5 % of women who take MivePristone have serious negative reactions, the report claims that the real number is about 11 %.
Researchers who study reproductive health said that it amounts to unwanted science and exaggerates the dangers of the drug.
“We must be concerned that people responsible for our public health institutions are calling for a review of science based on an uncompromising and defective report,” said Dr. Oshama Obada, a public health scientist at the University of California, San Francisco, said on Thursday at the invitation of members of the press.
She added, “Strict studies, including some of my country, have confirmed that this drug can be used safely at home after consulting with a doctor.”
The report said that his analysis depended on 865,727 requests to secure the women who were described as abortion pills, but they do not reveal the database that I used, and it wanders in the doctrine of scientific research. Many external researchers noted that the report of the report of a “serious, serious event” is wide enough to include simple side effects such as routine bleeding. But the authors of the report said on the center’s website that they are Light or moderate events excluded.
However, abortion procedures were classified after drug abortion as “dangerous”, unlike the medical consensus. The MivePristone sign is already that the drug does not work in about 2.6 % of cases, and doctors say the failure rate can reach 5 %. The report also lists ectopic pregnancies, which are not caused by taking MIFEPRISTONE, as serious events.
The report, “Alena Skancov, director of the Women’s Health Policy Program at KFF, a health policy research and research organization, said the report” is less than acceptable research standards in general. ” She added that the analysis of insurance claims is not an effective way to consider the results of abortion, because “many abortion operations, especially previous abortion operations, are not paid for insurance.”
Rachel Jones, a major research scientist at the Goette Maktarate Institute, a research organization that supports access to abortion, said the report appears to be driven by ideology instead of science.
She said: “FDA usually depends on clinical studies and clinical research, and this is not what it is. It should not have any impact on the current policies.”
The authors of the report have pushed these criticisms and writing On the center’s website The process of reviewing the peacocks is biased against groups that oppose abortion and leave “there are no opportunities to publish analyzes that the peers reviewed, which provide great fundamental criticism of the abortion or abortion pills.”
“Now that the largest study has ever revealed the abortion pills about the fact that they are not safe or effective, as she chose to manufacture lying about the results we reached to protect its profits at a huge cost to women’s health,” Hunter Ests, Director of Communications at the Ethics and Public Policy Center said in a statement.
The report is the report, the report is an indication that the FDA needs to look closely at the safety of MivePristone.
She said: “We have now asked the FDA now for years to make a more comprehensive review of the actual complications rate in the real world.” “For me, this report could not come soon enough.”
HHS, which deals with media inquiries on behalf of the FDA, did not respond to the comment request.
Reproductive health researchers said that the launch of defective studies is one of the many tactics used by anti -abortion groups to limit Pressure on federal officials.
Jones said: “People and organizations that want to abort the completion of abortion are producing these types of leaves more commonly,” Jones said.
Fair studies played a role in the previous legal challenge to reach the MivePristone that was finally presented by the Supreme Court. In a short time, MivePristone agreed in 2023, the American boycott judge Matthew Kacmarik was martyred with studies from an anti -abortion group that was later. Retreat.
The general lawyers in the state of Idahu, Kandas and Missouri tried to revive the lawsuit in October, and filed a case in the same federal court in Texas. But the Trump administration earlier this month told the judge to reject it.
Julia Kai, chief staff lawyer for the Reproductive Freedom Project in the American Civil Liberties Union, said in a press invitation that following the case may have undermined the legal defenses of the administration in other continuous lawsuits. Other legal experts see it as an attempt to avoid a firm position on abortion, which Trump should be left to individual states.
In his assertion sessions, Kennedy promised himself to agree with Trump on this issue. Also on Wednesday suggested that Trump will have a final opinion on how to organize MivePristone in the United States
“I feel that political changes will eventually go to the White House, through President Trump,” he said.
